HUTCHMED (China) (HCM) Research & Development (2018 - 2021)

HUTCHMED (China) (HCM) has 4 years of Research & Development data on file, last reported at -$66.0 million in Q2 2021.

• Research & Development for Q2 2021 came in at -$66.0 million, down 51.83% year-over-year; the trailing twelve-month figure through Jun 2021 was -$197.0 million (down 37.9% YoY), and the FY2025 annual result was -$19.1 million, up 30.12% from the prior year.
• Research & Development slipped to -$66.0 million in Q2 2021 per HCM's latest filing, from -$57.1 million in the prior quarter.
• Over five years, Research & Development peaked at $88.7 million in Q2 2018 and troughed at -$102.6 million in Q2 2019.
• A 4-year average of -$18.4 million and a median of -$31.0 million in 2019 frame the typical range for Research & Development.
• On a YoY basis, Research & Development climbed as much as 216.11% in 2019 and fell as far as 247.29% in 2019.
• A 4-year view of Research & Development shows it stood at $25.4 million in 2018, then sank by 247.29% to -$37.5 million in 2019, then declined by 16.04% to -$43.5 million in 2020, then slumped by 51.83% to -$66.0 million in 2021.
• Business Quant data shows HCM's Research & Development at -$66.0 million in Q2 2021, -$57.1 million in Q1 2021, and -$43.5 million in Q2 2020.